04/Jul 2008 | Pediatric Liver Transplant Patients Enjoy Good Quality of Life Years After Surgery | George Mazariegos, MD, is director of Pediatric Transplantation at Children s Hospital of Pittsburgh of UPMC and the Thomas E. Mazariegos is leading clinical efforts to evaluate lowering or withdrawal... Read » |
04/Jul 2008 | Hepatitis C Vaccine Delivered By Inovio Biomedical's Electroporation System Shows Increased T-Cell Responses And Reduced Viral Loads, Study | Hepatitis C Vaccine Delivered By Inovio Biomedical's Electroporation System Shows Increased T-Cell Responses And Reduced Viral Loads, Study - Health News from Medical News Today Jul 4, 2008, 6:15 am ... Read » |
04/Jul 2008 | Are you going to the party? | UnitedHealth Group Announces Lower Profit Outlook, Will Restructure To Focus More On Regional Coverage . Men, Blacks In Particular, Less Likely Than Women To Be Aware That They Have High Blood Pressu... Read » |
04/Jul 2008 | Entecavir (Baraclude) Produces Continued Clinical Benefits at 96 Weeks in Chronic Hepatitis B Patients Resistant to Lamivudine (Epivir-HBV) | Entecavir (Baraclude) Produces Continued Clinical Benefits at 96 Weeks in Chronic Hepatitis B Patients Resistant to Lamivudine (Epivir-HBV)s . The nucleoside analog entecavir (Baraclude) demonstrate... Read » |
04/Jul 2008 | European Commission Approves Shorter 16-week Course of Pegasys plus Ribavirin for Rapid Responders with HCV Genotypes 2 or 3 and Low Viral Load | European Commission Approves Shorter 16-week Course of Pegasys plus Ribavirin for Rapid Responders with HCV Genotypes 2 or 3 and Low Viral Load . Given that interferon-based therapy for chronic hepa... Read » |
04/Jul 2008 | HCV Genotype 1 Patients with High Viral Load Do Better with 48 vs 24 Weeks of Treatment, despite Rapid Virological Response | HCV Genotype 1 Patients with High Viral Load Do Better with 48 vs 24 Weeks of Treatment, despite Rapid Virological Response. Several studies have shown that individuals who experience rapid virologica... Read » |
04/Jul 2008 | New Tipranavir (Aptivus) Oral Solution Approved for Treatment-experienced Children and Adolescents with HIV | New Tipranavir (Aptivus) Oral Solution Approved for Treatment-experienced Children and Adolescents with HIV . In late June, Boehringer Ingelheim announced that the Food and Drug Administration grante... Read » |
04/Jul 2008 | Effect on Hepatitis C Virus Load in HIV-HCV Coinfected Patients Who Start Protease Inhibitor-based HAART | Effect on Hepatitis C Virus Load in HIV-HCV Coinfected Patients Who Start Protease Inhibitor-based HAART . It has been established that hepatitis C virus (HCV) genotype and HCV viral load are the str... Read » |
04/Jul 2008 | Resveratrol improves health, mimics some benefits of dietary restriction | Sirtris, a GlaxoSmithKline company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes , is included among a research team that reported in on... Read » |
04/Jul 2008 | Pharmacognostical studies on Buhiniea purpureaLinn.Leaves | The last one in this series is liver cancer. More than 2,50,000 people die of liver cancer every year worldwide. Liver cancer is difficult to control and hard to detect in its early stages. Ironically... Read » |
04/Jul 2008 | Multimillion dollar grant awarded to the Texas Medical Center Digestive Diseases Center | 3, 2008) -- A $5.8 million grant from the National Institutes of Health assures the continuation of the Texas Medical Center Digestive Diseases Center, a collaboration among Baylor College of Medicine... Read » |